Hypercortisolism in patients with cholestasis is associated with disease severity.
Adrenal gland
Bile acids
Bilirubin
Cholestasis
Cortisol
Hypothalamic–pituitary–adrenal axis (HPA axis)
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
07 Dec 2021
07 Dec 2021
Historique:
received:
30
12
2020
accepted:
24
11
2021
entrez:
8
12
2021
pubmed:
9
12
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), but supraphysiological bile acid levels were found to stimulate steroidogenesis independent of FXR and TGR5. Our previous experimental findings revealed that mice fed bile acids or subjected to common bile duct ligation develop hypercortisolemia. We thus aimed to assess adrenal gland function in patients with cholestasis. Adrenal gland function was assessed in 36 patients with cholestasis and in 32 patients without cholestasis by measuring total serum cortisol, adrenocorticotropic hormone (ACTH), as well as the increase of cortisol 20 and 30 min after administration of 1 µg of ACTH. Bile acid levels and bile acid pool composition were determined by high-resolution mass spectrometry. Patients with cholestasis per definition had markedly elevated levels of alkaline phosphatase (AP), bilirubin and serum bile acids. Baseline cortisol and maximum cortisol after ACTH stimulation were significantly higher in patients with cholestasis compared to controls. Increase of cortisol after ACTH stimulation and ACTH did not differ. In the cholestasis group, baseline cortisol correlated with bilirubin but not with AP, total serum bile acids and levels of conjugated and unconjugated bile acid species. Patients with duration of cholestasis < 6 months (n = 30) had significantly higher baseline cortisol levels than those with long standing cholestasis (> 6 months), together with higher bilirubin levels. We find no evidence of adrenal insufficiency in non-cirrhotic patients with cholestasis. In contrast, patients with cholestasis show hypercortisolism associated with disease severity as mirrored by levels of bilirubin. Lack of ACTH increase in cholestasis suggests a direct effect of cholestasis on adrenals and not on the pituitary gland. Further studies are needed to elucidate the mechanism of cortisol elevation in patients with cholestasis and its clinical significance.
Sections du résumé
BACKGROUND
BACKGROUND
Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), but supraphysiological bile acid levels were found to stimulate steroidogenesis independent of FXR and TGR5. Our previous experimental findings revealed that mice fed bile acids or subjected to common bile duct ligation develop hypercortisolemia. We thus aimed to assess adrenal gland function in patients with cholestasis.
METHODS
METHODS
Adrenal gland function was assessed in 36 patients with cholestasis and in 32 patients without cholestasis by measuring total serum cortisol, adrenocorticotropic hormone (ACTH), as well as the increase of cortisol 20 and 30 min after administration of 1 µg of ACTH. Bile acid levels and bile acid pool composition were determined by high-resolution mass spectrometry.
RESULTS
RESULTS
Patients with cholestasis per definition had markedly elevated levels of alkaline phosphatase (AP), bilirubin and serum bile acids. Baseline cortisol and maximum cortisol after ACTH stimulation were significantly higher in patients with cholestasis compared to controls. Increase of cortisol after ACTH stimulation and ACTH did not differ. In the cholestasis group, baseline cortisol correlated with bilirubin but not with AP, total serum bile acids and levels of conjugated and unconjugated bile acid species. Patients with duration of cholestasis < 6 months (n = 30) had significantly higher baseline cortisol levels than those with long standing cholestasis (> 6 months), together with higher bilirubin levels.
CONCLUSIONS
CONCLUSIONS
We find no evidence of adrenal insufficiency in non-cirrhotic patients with cholestasis. In contrast, patients with cholestasis show hypercortisolism associated with disease severity as mirrored by levels of bilirubin. Lack of ACTH increase in cholestasis suggests a direct effect of cholestasis on adrenals and not on the pituitary gland. Further studies are needed to elucidate the mechanism of cortisol elevation in patients with cholestasis and its clinical significance.
Identifiants
pubmed: 34876016
doi: 10.1186/s12876-021-02045-4
pii: 10.1186/s12876-021-02045-4
pmc: PMC8650422
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
460Informations de copyright
© 2021. The Author(s).
Références
Metabolism. 2004 Jun;53(6):811-6
pubmed: 15164334
J Hepatol. 2001 Sep;35(3):329-37
pubmed: 11592593
Annu Rev Nutr. 2019 Aug 21;39:175-200
pubmed: 31018107
Mol Cell Endocrinol. 2009 Feb 27;299(2):153-62
pubmed: 19059462
Mol Cell Endocrinol. 2012 Oct 15;362(1-2):69-75
pubmed: 22643070
Eur J Endocrinol. 2000 Feb;142(2):200-7
pubmed: 10664531
Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):243-251
pubmed: 30463692
J Pediatr Endocrinol Metab. 2018 Jan 26;31(2):107-115
pubmed: 29194043
Lancet. 1988 Oct 29;2(8618):986-9
pubmed: 2902493
Hepatology. 2013 Nov;58(5):1757-65
pubmed: 23728792
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
Med Res Rev. 2020 Jul;40(4):1335-1351
pubmed: 32017160
Arch Surg. 1960 Aug;81:334-40
pubmed: 13844925
Hepatology. 2007 Sep;46(3):776-84
pubmed: 17668874
Liver Int. 2018 Sep;38(9):1520-1535
pubmed: 29758112
EMBO J. 2006 Apr 5;25(7):1419-25
pubmed: 16541101
Hepatology. 1999 Sep;30(3):623-9
pubmed: 10462366
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
Clin Liver Dis. 2008 Feb;12(1):1-26, vii
pubmed: 18242495
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1319-1325
pubmed: 28844960
Surgery. 1956 Jun;39(6):1016-30
pubmed: 13324618
Hepatology. 2006 Oct;44(4):795-801
pubmed: 17006915
Annu Rev Biochem. 1975;44:233-53
pubmed: 1094911
Hepatology. 2017 Apr;65(4):1393-1404
pubmed: 27997980
Clin Gastroenterol Hepatol. 2014 Mar;12(3):504-12.e8; quiz e23-4
pubmed: 23978347
Hepatology. 2012 Apr;55(4):1282-91
pubmed: 22234976
Crit Care Med. 2017 Dec;45(12):2078-2088
pubmed: 28938253
J Biol Chem. 2003 Jan 3;278(1):104-10
pubmed: 12393883
Clin Chim Acta. 2017 Jan;464:85-92
pubmed: 27838249
Physiol Rev. 2009 Jan;89(1):147-91
pubmed: 19126757
Liver Int. 2019 Nov;39(11):2112-2123
pubmed: 30664326
Gastroenterology. 1998 Jan;114(1):175-84
pubmed: 9428231
J Hepatol. 2010 May;52(5):705-11
pubmed: 20347173